Nutrien Ltd. (NYSE:NTR) Shares Acquired by Atria Investments Inc

Atria Investments Inc lifted its stake in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 2.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,636 shares of the company’s stock after buying an additional 290 shares during the period. Atria Investments Inc’s holdings in Nutrien were worth $703,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Central Pacific Bank Trust Division purchased a new stake in shares of Nutrien in the 3rd quarter valued at $28,000. Family Firm Inc. acquired a new stake in Nutrien during the 2nd quarter worth about $32,000. Trust Co. of Vermont raised its stake in shares of Nutrien by 50.0% during the 2nd quarter. Trust Co. of Vermont now owns 900 shares of the company’s stock valued at $46,000 after buying an additional 300 shares during the last quarter. Covestor Ltd lifted its holdings in shares of Nutrien by 33.3% in the 1st quarter. Covestor Ltd now owns 932 shares of the company’s stock valued at $50,000 after buying an additional 233 shares during the period. Finally, Andra AP fonden purchased a new stake in shares of Nutrien in the second quarter worth about $51,000. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Price Performance

Shares of NTR opened at $45.60 on Tuesday. The firm has a 50-day simple moving average of $47.98 and a two-hundred day simple moving average of $50.34. The stock has a market cap of $22.52 billion, a PE ratio of 30.60, a P/E/G ratio of 1.58 and a beta of 0.82. Nutrien Ltd. has a 1-year low of $44.65 and a 1-year high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The firm had revenue of $5.35 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the prior year, the firm posted $0.35 EPS. Nutrien’s quarterly revenue was down 5.0% compared to the same quarter last year. As a group, analysts forecast that Nutrien Ltd. will post 3.59 EPS for the current year.

Nutrien Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 17th. Investors of record on Tuesday, December 31st will be issued a $0.939 dividend. The ex-dividend date is Tuesday, December 31st. This is a positive change from Nutrien’s previous quarterly dividend of $0.54. This represents a $3.76 dividend on an annualized basis and a yield of 8.24%. Nutrien’s dividend payout ratio (DPR) is 144.97%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Scotiabank dropped their price target on shares of Nutrien from $66.00 to $59.00 and set a “sector outperform” rating on the stock in a research report on Monday, August 12th. Royal Bank of Canada restated an “outperform” rating and issued a $60.00 price target on shares of Nutrien in a research note on Friday, September 20th. UBS Group cut Nutrien from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $66.00 to $51.00 in a report on Thursday, October 10th. HSBC lowered Nutrien from a “hold” rating to a “reduce” rating in a report on Friday, August 2nd. Finally, Barclays reduced their target price on Nutrien from $68.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday, August 16th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $60.33.

View Our Latest Stock Report on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.